Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pro Pharmaceuticals Group is an Australian specialty pharmaceutical company that focuses on the sourcing, registration, and distribution of niche and hard-to-find medicines. The company plays a critical role in the healthcare system by managing medicine shortages and providing access to essential treatments through the Therapeutic Goods Administration (TGA) Special Access Scheme and Section 19A approvals. Their product portfolio covers a wide range of therapeutic areas, including oncology, hematology, anti-infectives, and endocrinology. PPG works closely with global manufacturing partners to ensure a consistent supply of high-quality pharmaceuticals to hospitals and pharmacies across Australia. By bridging the gap between international supply and local demand, the company helps clinicians provide uninterrupted care to patients with specialized medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pro Pharmaceuticals Group.